×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Chaperone-Mediated Proteostasis in 4R-Tauopathies
mechanism
1,521 words
KG: Chaperone-Mediated Proteostasis in 4R-Tauopathies
2026-03-28
evidence:strong
mechanism
mechanisms
published
psp
cbd
ftd
Contents
Chaperone-Mediated Proteostasis in 4R-Tauopathies
⚙
Mechanism Info
Name
Chaperone-Mediated Proteostasis in 4R-Tauopathies
Category
evidence:strong
Summary
Cross-disease comparison of HSP70 chaperones, proteasome-mediated degradation, CMA, and small HSPs across PSP, CBD, AGD, GGT, and FTDP-17
Knowledge Graph
Related Hypotheses (26)
Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.50
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
Glycosaminoglycan Template Disruption Approach
Score: 0.46
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor
Score: 0.42
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor
Score: 0.42
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55
Dual-Circuit Tau Vulnerability Cascade
Score: 0.50
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.45
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44
VCP-Mediated Autophagy Enhancement
Score: 0.41
GAP43-mediated tunneling nanotube stabilization enhances neu
Score: 0.38
KDM6A-Mediated H3K27me3 Rejuvenation
Score: 0.38
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Show 21 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Show 25 more
Related Experiments (5)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40